vimarsana.com

Page 6 - Sandeep Kulkarni News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement - Talaris Therapeutics (NASDAQ:TALS)

Merger to create Nasdaq-listed, late-stage clinical biotechnology company focused on developing Tourmaline's anti-IL-6 antibody (TOUR006) in thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD)

Talaris Therapeutics (TALS) and Tourmaline Bio Announce Merger Agreement

Talaris Therapeutics (TALS) and Tourmaline Bio Announce Merger Agreement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Biotech company with Louisville ties to live on through merger

The announcement follows Talaris Therapeutics’ unsuccessful effort to commercialize a stem cell therapy that promised to improve transplant recipients’ tolerance of new organs.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.